Global Blood Therapeutics, Inc. (GBT) Social Stream



Global Blood Therapeutics, Inc. (GBT): $28.69

-0.75 (-2.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GBT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 498

in industry

Featured Post From StockTwits About GBT

$GBT treats one of the most prevalent diseases that afflicts black Americans (sickle cell disease). The company has a large short interest and at these depressed prices is an excellent takover candidate . A leading Oppenheimer analyst that has an impeccable track record has a price target roughly 130% higher. JPM analyst downgraded stock today which presents interesting entry point.

https://utradea.com/positions/GBT_savior_of_Black_Americans
Utradea, published July 13, 2021

Other Notable StockTweets About GBT


$GBT reported 4 new insider trades to the SEC in the last 2 minutes.

$38,915.10 of shares sold by Pizzo Philip A. (Director) https://newsfilter.io/articles/4-form-1d21c96bf58604c68f77c17e36714f5d
3,037 shares acquired by Brown Willie L. Jr. (Director) https://newsfilter.io/articles/4-form-f557f0d9c82edde51c36d1845efbe60f
3,037 shares acquired by Morrison Scott W (Director) https://newsfilter.io/articles/4-form-d34e9de08dba5ddff54b36a4395fb2c2
3,037 shares acquired by Patrick Deval L (Director) https://newsfilter.io/articles/4-form-cd799378a8c258e6e45bfadffa3cd602

Newsfilter, published June 21, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5512 seconds.